Latanoprost: Uses, Interactions, Mechanism Of Action

USES

• Primary Open-Angle Glaucoma (POAG): Latanoprost lowers IOP in primary open-angle glaucoma, the most common kind worldwide. Eye pressure reduction prevents progressive optic neuropathy and vision loss. Many patients choose prostaglandin analogs like latanoprost because they function, are safe, and only need to be taken once a day, making it easier to follow the treatment regimen.
• Off-Label Uses: Latanoprost is also used to treat people suffering from ocular hypertension, which means they have high IOP but no damage to the optic nerve that can be seen. These kinds of people are very likely to get glaucoma, but the risk can be greatly lowered if IOP-lowering drugs are used early.
• Off-Label Uses: Although less common, latanoprost may be used off-label for certain types of secondary glaucoma, such as pigmentary or pseudo exfoliative glaucoma. It has also been studied in combination therapies when monotherapy is insufficient to achieve target pressures

MECHANISM OF ACTION

Latanoprost is a prodrug—it becomes active after being converted into latanoprost acid in the eye. Its therapeutic effect stems from its action as a selective prostaglandin F2α (FP) receptor agonist.

• Enhanced Uveoscleral Outflow: The primary effect of Latanoprost is to improve the uveoscleral outflow which is the second route by which aqueous fluid can be drained. Latanoprost facilitates the removal of fluid by the ciliary muscle and surrounding tissues as opposed to b-blockers and carbonic anhydrase inhibitors which reduce the secretion of watery humour.

It does this by:

• Remodeling the extracellular matrix of the ciliary muscle
• Reducing resistance to aqueous humor escape
• Increasing overall fluid drainage from the eye

This leads to a sustained reduction in intraocular pressure.

• Long Duration of Action: The effect of the drug lasts 24 hours and therefore can be used once a day. The evening administration can help improve the effectiveness and can minimise the side effects during the day like conjunctival hyperaemia.
• Minimal Impact on Aqueous Humour Secretion: Unlike other antiglaucomics, latanoprost does not have a significant effect on aqueous humour secretion which is why it has no side effects in the body that b-blockers or a-agonists have.

DRUG INTERACTIONS

Although latanoprost is applied topically, there are meaningful interactions to consider:

• Other Prostaglandin Analogs: Combining latanoprost with other prostaglandin analogs can reduce overall efficacy and increase paradoxical IOP elevation. Therefore, prostaglandin analogs are typically not used together.
• Eye Drops Containing Thimerosal: Thimerosal is a preservative found in some ophthalmic solutions, which may form precipitates when used simultaneously with latanoprost. Spacing doses by several minutes is recommended.
• b-Blocker, Carbonic Anhydrase Inhibitor or a-Agonist Eye Drops: No known harmful interaction has been identified but the medications are usually used in combination with latanoprost to achieve additive IOP reduction. Nonetheless, combinations should be observed so that the best pressure could be ensured.
• Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Topical NSAIDs may theoretically reduce the IOP-lowering effect of prostaglandin analogs by inhibiting prostaglandin receptor pathways, though this interaction is not universally observed.
• Contact Lenses: Soft contact lenses can absorb the preservatives found in latanoprost. Patients should remove lenses before applying and wait at least 15 minutes before reinserting them.

CONCLUSION

Latanoprost is very effective and a first-line treatment of reducing the intraocular pressure of glaucoma and ocular hypertension. Its action, improvement of uveoscleral outflow through FP receptor stimulation, provides powerful, prolonged pressure changes with minimal systemic side effects. Although it is usually well tolerated, interactions with other eye drops, prostaglandin analogues, and some preservatives should be noticed in order to make the therapy safe and optimised. Since glaucoma is one of the gravest causes of permanent blindness, the use of such drugs as latanoprost plays a crucial role in saving vision and preventing the development of the disease.